Loading…

Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study

Background and Objectives To evaluate the risk of coronary heart disease (CHD) associated with metabolic syndrome (MetS) and its individual components in a representative sample of diabetic and nondiabetic Iranians. Moreover, we aimed to define the most hazardous MetS components. Methods Two cohorts...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical lipidology 2014-05, Vol.8 (3), p.279-286
Main Authors: Esteghamati, Alireza, MD, Hafezi-Nejad, Nima, MPH, MD, Sheikhbahaei, Sara, MPH, MD, Heidari, Behnam, MPH, MD, Zandieh, Ali, MPH, MD, Ebadi, Maryam, MD, Nakhjavani, Manouchehr, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033
cites cdi_FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033
container_end_page 286
container_issue 3
container_start_page 279
container_title Journal of clinical lipidology
container_volume 8
creator Esteghamati, Alireza, MD
Hafezi-Nejad, Nima, MPH, MD
Sheikhbahaei, Sara, MPH, MD
Heidari, Behnam, MPH, MD
Zandieh, Ali, MPH, MD
Ebadi, Maryam, MD
Nakhjavani, Manouchehr, MD
description Background and Objectives To evaluate the risk of coronary heart disease (CHD) associated with metabolic syndrome (MetS) and its individual components in a representative sample of diabetic and nondiabetic Iranians. Moreover, we aimed to define the most hazardous MetS components. Methods Two cohorts consisting of 1737 nondiabetic and 2385 diabetic participants were followed for the first CHD event during 8.5 years (until December 2013). Results MetS is defined as having 3 individual components associated with increased risk of CHD (hazard ratio [HR] for MetS: in the unadjusted were 2.85 [2.27–3.57] and in the fully adjusted model 1.80 [1.42–2.28]). MetS was associated with lower hazard of CHD in subjects older than 65 (HR: 1.50 vs. 3.47; P for interaction < .05) and in men (HR: 1.68 vs. 4.87; P for interaction
doi_str_mv 10.1016/j.jacl.2014.02.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1521333794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1933287414000415</els_id><sourcerecordid>1521333794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033</originalsourceid><addsrcrecordid>eNp9Ustu1TAUjBCIlsIPsEBeskk4fuQmQQipqnhUqoTEY2059omu08S--CRF9xv4aRxuYcGClS17ZuyZOUXxnEPFge9ejdVo7FQJ4KoCUQGIB8U5b5tdqZq2e5j3nZSlaBt1VjwhGgHquoH6cXEmVJOvVHde_Pzs6ZbFgdmYYjDpyPZo0sKcJzSEzBBF682Cjv3wy57NuJg-Tt4yOgaX4pwhwTG_EPPB-TvvVjNlsfkQA4bfp-w6meBNYLT2I9qFXrNLNpvF7rOojfuYn6NldcenxaPBTITP7teL4tv7d1-vPpY3nz5cX13elFZxvpSdshx2Mtt1ojZCcdG4xg5SgexaB9lZa0FJu3O87S2XCLAD6GEYhqblIOVF8fKke0jx-4q06NmTxWkyAeNKmteCSymbTmWoOEFtikQJB31Ifs4xaQ56K0GPeitBbyVoEDr_KpNe3Ouv_YzuL-VP6hnw5gTA7PLOY9JkPQaLzqcckHbR_1__7T90O_ngrZlu8Yg0xjWFnJ_mmjJBf9nGYJsCrgBA8Vr-Aghdrik</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521333794</pqid></control><display><type>article</type><title>Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study</title><source>ScienceDirect Freedom Collection</source><creator>Esteghamati, Alireza, MD ; Hafezi-Nejad, Nima, MPH, MD ; Sheikhbahaei, Sara, MPH, MD ; Heidari, Behnam, MPH, MD ; Zandieh, Ali, MPH, MD ; Ebadi, Maryam, MD ; Nakhjavani, Manouchehr, MD</creator><creatorcontrib>Esteghamati, Alireza, MD ; Hafezi-Nejad, Nima, MPH, MD ; Sheikhbahaei, Sara, MPH, MD ; Heidari, Behnam, MPH, MD ; Zandieh, Ali, MPH, MD ; Ebadi, Maryam, MD ; Nakhjavani, Manouchehr, MD</creatorcontrib><description>Background and Objectives To evaluate the risk of coronary heart disease (CHD) associated with metabolic syndrome (MetS) and its individual components in a representative sample of diabetic and nondiabetic Iranians. Moreover, we aimed to define the most hazardous MetS components. Methods Two cohorts consisting of 1737 nondiabetic and 2385 diabetic participants were followed for the first CHD event during 8.5 years (until December 2013). Results MetS is defined as having 3 individual components associated with increased risk of CHD (hazard ratio [HR] for MetS: in the unadjusted were 2.85 [2.27–3.57] and in the fully adjusted model 1.80 [1.42–2.28]). MetS was associated with lower hazard of CHD in subjects older than 65 (HR: 1.50 vs. 3.47; P for interaction &lt; .05) and in men (HR: 1.68 vs. 4.87; P for interaction &lt; .05). Presence of 4 of 5 individual MetS components increased the risk of CHD associated with MetS as a constellation. The value of MetS is augmented in the presence of low high-density lipoprotein-cholesterol (HR: 5.74 [2.52–13.08]) versus its absence (HR 1.91 [1.33–2.75]), high triglycerides (HR: 3.39 [1.38–8.34] vs. 1.99 [1.40–2.82] in its absence) and elevated blood pressure (HR: 2.61 [1.43–4.76] vs. 1.80 [1.26–2.58] in its absence). Conclusions We address the value of MetS components in the prediction of CHD and in the absence of traditional risk factors. This study provides evidence for the synergistic effect of MetS components on the incidence of CHD.</description><identifier>ISSN: 1933-2874</identifier><identifier>EISSN: 1876-4789</identifier><identifier>DOI: 10.1016/j.jacl.2014.02.002</identifier><identifier>PMID: 24793349</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Age Factors ; Aged ; Cardiovascular ; Cholesterol - metabolism ; Cohort ; Cohort Studies ; Coronary Disease - epidemiology ; Coronary heart disease ; Diabetes Complications - epidemiology ; Epidemiology ; Female ; Follow-Up Studies ; Humans ; Hypertension ; Hypertriglyceridemia ; Incidence ; Iran ; Lipoproteins, HDL - metabolism ; Low HDL-C ; Male ; Metabolic syndrome ; Metabolic Syndrome - complications ; Metabolic Syndrome - epidemiology ; Middle Aged ; Risk Factors ; Sex Factors ; Triglycerides - metabolism</subject><ispartof>Journal of clinical lipidology, 2014-05, Vol.8 (3), p.279-286</ispartof><rights>National Lipid Association</rights><rights>2014 National Lipid Association</rights><rights>Copyright © 2014 National Lipid Association. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033</citedby><cites>FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24793349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esteghamati, Alireza, MD</creatorcontrib><creatorcontrib>Hafezi-Nejad, Nima, MPH, MD</creatorcontrib><creatorcontrib>Sheikhbahaei, Sara, MPH, MD</creatorcontrib><creatorcontrib>Heidari, Behnam, MPH, MD</creatorcontrib><creatorcontrib>Zandieh, Ali, MPH, MD</creatorcontrib><creatorcontrib>Ebadi, Maryam, MD</creatorcontrib><creatorcontrib>Nakhjavani, Manouchehr, MD</creatorcontrib><title>Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study</title><title>Journal of clinical lipidology</title><addtitle>J Clin Lipidol</addtitle><description>Background and Objectives To evaluate the risk of coronary heart disease (CHD) associated with metabolic syndrome (MetS) and its individual components in a representative sample of diabetic and nondiabetic Iranians. Moreover, we aimed to define the most hazardous MetS components. Methods Two cohorts consisting of 1737 nondiabetic and 2385 diabetic participants were followed for the first CHD event during 8.5 years (until December 2013). Results MetS is defined as having 3 individual components associated with increased risk of CHD (hazard ratio [HR] for MetS: in the unadjusted were 2.85 [2.27–3.57] and in the fully adjusted model 1.80 [1.42–2.28]). MetS was associated with lower hazard of CHD in subjects older than 65 (HR: 1.50 vs. 3.47; P for interaction &lt; .05) and in men (HR: 1.68 vs. 4.87; P for interaction &lt; .05). Presence of 4 of 5 individual MetS components increased the risk of CHD associated with MetS as a constellation. The value of MetS is augmented in the presence of low high-density lipoprotein-cholesterol (HR: 5.74 [2.52–13.08]) versus its absence (HR 1.91 [1.33–2.75]), high triglycerides (HR: 3.39 [1.38–8.34] vs. 1.99 [1.40–2.82] in its absence) and elevated blood pressure (HR: 2.61 [1.43–4.76] vs. 1.80 [1.26–2.58] in its absence). Conclusions We address the value of MetS components in the prediction of CHD and in the absence of traditional risk factors. This study provides evidence for the synergistic effect of MetS components on the incidence of CHD.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Cardiovascular</subject><subject>Cholesterol - metabolism</subject><subject>Cohort</subject><subject>Cohort Studies</subject><subject>Coronary Disease - epidemiology</subject><subject>Coronary heart disease</subject><subject>Diabetes Complications - epidemiology</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertriglyceridemia</subject><subject>Incidence</subject><subject>Iran</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Low HDL-C</subject><subject>Male</subject><subject>Metabolic syndrome</subject><subject>Metabolic Syndrome - complications</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Middle Aged</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Triglycerides - metabolism</subject><issn>1933-2874</issn><issn>1876-4789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9Ustu1TAUjBCIlsIPsEBeskk4fuQmQQipqnhUqoTEY2059omu08S--CRF9xv4aRxuYcGClS17ZuyZOUXxnEPFge9ejdVo7FQJ4KoCUQGIB8U5b5tdqZq2e5j3nZSlaBt1VjwhGgHquoH6cXEmVJOvVHde_Pzs6ZbFgdmYYjDpyPZo0sKcJzSEzBBF682Cjv3wy57NuJg-Tt4yOgaX4pwhwTG_EPPB-TvvVjNlsfkQA4bfp-w6meBNYLT2I9qFXrNLNpvF7rOojfuYn6NldcenxaPBTITP7teL4tv7d1-vPpY3nz5cX13elFZxvpSdshx2Mtt1ojZCcdG4xg5SgexaB9lZa0FJu3O87S2XCLAD6GEYhqblIOVF8fKke0jx-4q06NmTxWkyAeNKmteCSymbTmWoOEFtikQJB31Ifs4xaQ56K0GPeitBbyVoEDr_KpNe3Ouv_YzuL-VP6hnw5gTA7PLOY9JkPQaLzqcckHbR_1__7T90O_ngrZlu8Yg0xjWFnJ_mmjJBf9nGYJsCrgBA8Vr-Aghdrik</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Esteghamati, Alireza, MD</creator><creator>Hafezi-Nejad, Nima, MPH, MD</creator><creator>Sheikhbahaei, Sara, MPH, MD</creator><creator>Heidari, Behnam, MPH, MD</creator><creator>Zandieh, Ali, MPH, MD</creator><creator>Ebadi, Maryam, MD</creator><creator>Nakhjavani, Manouchehr, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201405</creationdate><title>Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study</title><author>Esteghamati, Alireza, MD ; Hafezi-Nejad, Nima, MPH, MD ; Sheikhbahaei, Sara, MPH, MD ; Heidari, Behnam, MPH, MD ; Zandieh, Ali, MPH, MD ; Ebadi, Maryam, MD ; Nakhjavani, Manouchehr, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Cardiovascular</topic><topic>Cholesterol - metabolism</topic><topic>Cohort</topic><topic>Cohort Studies</topic><topic>Coronary Disease - epidemiology</topic><topic>Coronary heart disease</topic><topic>Diabetes Complications - epidemiology</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertriglyceridemia</topic><topic>Incidence</topic><topic>Iran</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Low HDL-C</topic><topic>Male</topic><topic>Metabolic syndrome</topic><topic>Metabolic Syndrome - complications</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Middle Aged</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Triglycerides - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esteghamati, Alireza, MD</creatorcontrib><creatorcontrib>Hafezi-Nejad, Nima, MPH, MD</creatorcontrib><creatorcontrib>Sheikhbahaei, Sara, MPH, MD</creatorcontrib><creatorcontrib>Heidari, Behnam, MPH, MD</creatorcontrib><creatorcontrib>Zandieh, Ali, MPH, MD</creatorcontrib><creatorcontrib>Ebadi, Maryam, MD</creatorcontrib><creatorcontrib>Nakhjavani, Manouchehr, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical lipidology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esteghamati, Alireza, MD</au><au>Hafezi-Nejad, Nima, MPH, MD</au><au>Sheikhbahaei, Sara, MPH, MD</au><au>Heidari, Behnam, MPH, MD</au><au>Zandieh, Ali, MPH, MD</au><au>Ebadi, Maryam, MD</au><au>Nakhjavani, Manouchehr, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study</atitle><jtitle>Journal of clinical lipidology</jtitle><addtitle>J Clin Lipidol</addtitle><date>2014-05</date><risdate>2014</risdate><volume>8</volume><issue>3</issue><spage>279</spage><epage>286</epage><pages>279-286</pages><issn>1933-2874</issn><eissn>1876-4789</eissn><abstract>Background and Objectives To evaluate the risk of coronary heart disease (CHD) associated with metabolic syndrome (MetS) and its individual components in a representative sample of diabetic and nondiabetic Iranians. Moreover, we aimed to define the most hazardous MetS components. Methods Two cohorts consisting of 1737 nondiabetic and 2385 diabetic participants were followed for the first CHD event during 8.5 years (until December 2013). Results MetS is defined as having 3 individual components associated with increased risk of CHD (hazard ratio [HR] for MetS: in the unadjusted were 2.85 [2.27–3.57] and in the fully adjusted model 1.80 [1.42–2.28]). MetS was associated with lower hazard of CHD in subjects older than 65 (HR: 1.50 vs. 3.47; P for interaction &lt; .05) and in men (HR: 1.68 vs. 4.87; P for interaction &lt; .05). Presence of 4 of 5 individual MetS components increased the risk of CHD associated with MetS as a constellation. The value of MetS is augmented in the presence of low high-density lipoprotein-cholesterol (HR: 5.74 [2.52–13.08]) versus its absence (HR 1.91 [1.33–2.75]), high triglycerides (HR: 3.39 [1.38–8.34] vs. 1.99 [1.40–2.82] in its absence) and elevated blood pressure (HR: 2.61 [1.43–4.76] vs. 1.80 [1.26–2.58] in its absence). Conclusions We address the value of MetS components in the prediction of CHD and in the absence of traditional risk factors. This study provides evidence for the synergistic effect of MetS components on the incidence of CHD.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24793349</pmid><doi>10.1016/j.jacl.2014.02.002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1933-2874
ispartof Journal of clinical lipidology, 2014-05, Vol.8 (3), p.279-286
issn 1933-2874
1876-4789
language eng
recordid cdi_proquest_miscellaneous_1521333794
source ScienceDirect Freedom Collection
subjects Adult
Age Factors
Aged
Cardiovascular
Cholesterol - metabolism
Cohort
Cohort Studies
Coronary Disease - epidemiology
Coronary heart disease
Diabetes Complications - epidemiology
Epidemiology
Female
Follow-Up Studies
Humans
Hypertension
Hypertriglyceridemia
Incidence
Iran
Lipoproteins, HDL - metabolism
Low HDL-C
Male
Metabolic syndrome
Metabolic Syndrome - complications
Metabolic Syndrome - epidemiology
Middle Aged
Risk Factors
Sex Factors
Triglycerides - metabolism
title Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A06%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20coronary%20heart%20disease%20associated%20with%20metabolic%20syndrome%20and%20its%20individual%20components%20in%20Iranian%20subjects:%20A%20matched%20cohort%20study&rft.jtitle=Journal%20of%20clinical%20lipidology&rft.au=Esteghamati,%20Alireza,%20MD&rft.date=2014-05&rft.volume=8&rft.issue=3&rft.spage=279&rft.epage=286&rft.pages=279-286&rft.issn=1933-2874&rft.eissn=1876-4789&rft_id=info:doi/10.1016/j.jacl.2014.02.002&rft_dat=%3Cproquest_cross%3E1521333794%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-94c1063002d25a24127d7cf340398d07938c043c6d18bc13e00600b0fff781033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1521333794&rft_id=info:pmid/24793349&rfr_iscdi=true